Mallinckrodt announces publication of two journal manuscripts with clinical and economic evidence for acthar® gel (repository corticotropin injection)
– clinical findings from historical manuscript published in clinical drug investigation reinforce the efficacy, safety profile, and use of acthar gel in appropriate patients across 12 autoimmune and inflammatory indications1 – – economic findings from manuscript published in clinicoeconomics and outcomes research support acthar gel's clinical and economic benefits for patients across nine autoimmune and inflammatory indications2 – dublin , oct. 10, 2023 /prnewswire/ -- mallinckrodt plc (otcmkts: mnktq), a global specialty pharmaceutical company, today announced the publication of two journal manuscripts reinforcing the clinical and economic evidence supporting the efficacy, safety profile, continued use, and cost-effectiveness of acthar gel for appropriate patients across a range of fda-approved autoimmune and inflammatory disease indications.1,2 mallinckrodt's clinical manuscript titled "acthar gel treatment for patients with autoimmune and inflammatory diseases: a historical perspective and characterization of clinical evidence" was published on october 4, 2023 in the journal, clinical drug investigation. mallinckrodt's health economics manuscript titled "acthar gel (rci): a narrative literature review of clinical and economic evidence" was published on june 24, 2023 in clinicoeconomics and outcomes research.
MNK Ratings Summary
MNK Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission